Meeting slides
Suggested Readings

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

Baeten JM, et al. N Engl J Med. 2012;367(5):399-410.

Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.

Choopanya K, et al. Lancet. 2013;381(9883):2083-2090.

Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.

Delany-Moretlwe S, et al. Lancet. 2022;399(10337):1779-1789.

Drug database: emtricitabine/tenofovir alafenamide.

Drug database: emtricitabine/tenofovir disoproxil fumarate.

Drug database: cabotegravir.

Being PrEPared—preexposure prophylaxis and HIV disparities.

Goldstein RH, et al. N Engl J Med. 2018;379(14):1293-1295.

'If the partner finds out, then there's trouble': provider perspectives on safety planning and partner interference when offering HIV pre-exposure prophylaxis (PrEP) to women experiencing intimate partner violence (IPV).

Jeffers NK, et al. AIDS Behav. 2022;26(7):2266-2278.

Lifetime risk of a diagnosis of HIV infection in the United States.

Hess KL, et al. Ann Epidemiol. 2017;27(4):238-243. 

Socioecological factors influencing women's HIV risk in the United States: qualitative findings from the women's HIV SeroIncidence study (HPTN 064).

Frew PM, et al. BMC Public Health. 2016;16(1):803.

Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial.

Mayer KH, et al. Lancet. 2020;396(10246):239-254.

Linked Resources


Preexposure prophylaxis for the prevention of HIV infection in the United States—2021 update. A clinical practice guideline.

US Public Health Service. Centers for Disease Control and Prevention.

Sexually transmitted infections treatment guidelines, 2021.

Workowski KA et al. MMWR Recomm Rep. 2021;70(4):1-187.

The Fenway Guide to Lesbian, Gay, Bisexual, and Transgender Health. 2nd ed.

Makadon HJ, et al; American College of Physicians, eds. Boston, MA: Fenway Health; 2015.

Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society—USA Panel. 

Saag MS, et al. JAMA. 2020;324(16):1651-1669.

Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Last updated March 2023.


American Academy of HIV Medicine.

AIDS Education & Training Center Program: National Coordinating Resource Center.

Provides consultation, training, and resources nationwide. 

A guide to taking a sexual history.

Centers for Disease Control and Prevention.

Basic statistics.

Centers for Disease Control and Prevention.

HIV testing.

Centers for Disease Control and Prevention.

Taking routine histories of sexual health: a system-wide approach for health centers.

National LGBTQIA+ Health Education Center.

Ending the HIV epidemic in the U.S.: Ready, Set, PrEP!

US Department of Health and Human Services.

Preexposure prophylaxis for the prevention of HIV infection in the United States—2021 update. Clinical providers’ supplement.

US Public Health Service. Centers for Disease Control and Prevention.

National Clinician Consultation Center.

University of California, San Francisco.

HIV drug interactions.

University of Liverpool.

Sexual history taking toolkit. Addressing STIs: Ask. Test. Treat. Repeat.



HIV Prevention Certified Provider™ Certification Program. 

Prepares MD, DO, NP, and PA to expand the HIV prevention workforce.


HIV basics.

Centers for Disease Control and Prevention.

Prevention for women. Resources on HIV prevention for U.S. women.

HIVE online.

Related activities

Understanding PrEP Needs in Women: HIV Prevention in OB/GYN Practice

An Interactive Professor™ Activity

Faculty: Renata Sanders, MD, MPH, ScM
Release: 10/20/2023
Expiration: 10/20/2024